Global Uterine Fibroids Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14461357 | Publishing Date : 19-Jul-2019 | No. of pages : 106
Patients suffering from uterine fibroid problem represent an undeserved and huge market due to the absence of satisfactory medical treatments. Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.
In 2018, the global Uterine Fibroids market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Uterine Fibroids status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Uterine Fibroids development in United States, Europe and China.
The key players covered in this study
Boston Scientific
Cooper Surgical
C.R. Bard
F. Hoffmann-La Roche
GE Healthcare
Karl Storz Endoscopy
Richard Wolf Medical Instruments
Siemens Medical Solutions
AbbVie
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline Pharmaceuticals
Pfizer
Johnson & Johnson
Novartis
Market segment by Type, the product can be split into
Non-Hormonal Treatment
Hormonal Treatment
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Uterine Fibroids status, future forecast, growth opportunity, key market and key players.
To present the Uterine Fibroids development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Uterine Fibroids are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region